Bristol-Myers Squibb's Ready. Raise. Rise.™ Recognizes 23 Cancer Advocacy Groups in Immuno-Oncology Research Awareness Camp...
October 13 2015 - 6:59AM
Business Wire
- More than 50,000 virtual flags raised
to honor loved ones and support cancer advocacy groups
- Charitable donations were awarded to
Chris4Life Colon Cancer Foundation, Cancer Support Community and
CancerCare for having the most flags raised on their behalf,
recognizing their commitment to increasing awareness of
Immuno-Oncology research
Bristol-Myers Squibb today announced that more than 50,000
virtual flags have been raised by Americans across the country as
part of the Ready. Raise. Rise. campaign, a program
dedicated to raising awareness and educating the public about an
exciting area of cancer research called Immuno-Oncology.
Twenty-three cancer advocacy organizations participated with
Bristol-Myers Squibb, along with two-time Emmy® award-winning actor
Eric Stonestreet, of television’s hit comedy “Modern Family,” to
launch Ready. Raise. Rise. in May.
The campaign encouraged people to visit ReadyRaiseRise.com to
create a personalized, virtual flag to honor a loved one touched by
cancer. Visitors could share the personalized flag on social media
using the hashtag #RaiseYourFlag, and select a cancer advocacy
organization they wished to support from among 23 participating
groups. The more than 50,000 flags that have been raised as part of
the campaign have helped generate increased attention to the field
of Immuno-Oncology, an area of research that aims to harness the
body’s own immune system to help fight cancer. Education about
Immuno-Oncology research is needed, as a survey that was conducted
prior to the launch of the campaign found that only 15 percent of
Americans were knowledgeable about this area of science.
“We are all too familiar with cancer and the impact it can have
on families and friendships. We are deeply moved by the number of
flags that have been raised to honor loved ones affected by cancer
as part of the Ready. Raise. Rise. campaign,” said Teresa
Bitetti, senior vice president, Oncology, Bristol-Myers Squibb. “It
is also inspiring to see the dedication the advocacy organizations
have for raising awareness of cancer research, but more
importantly, for supporting patients and families impacted by
cancer. We are proud to give back to the cancer community and honor
the 23 advocacy organizations who came together to help us educate
about Immuno-Oncology research and pay tribute to those touched by
cancer.”
As part of the campaign, three organizations among the 23 groups
have received a charitable donation from Bristol-Myers Squibb for
having the most flags raised on their behalf. Chris4Life Colon
Cancer Foundation, Cancer Support Community and CancerCare had a
combined total of 40,862 flags raised in their name, and have
received a donation of $75,000, $50,000 and $25,000,
respectively.
“On behalf of the recipients, we are proud to accept this
donation from Bristol-Myers Squibb and honored to have joined the
company and Eric Stonestreet in this important initiative,” said
Michael Sapienza, Founder and President, Chris4Life Colon Cancer
Foundation. “We were thrilled with the outpouring of support from
the cancer community and appreciative of efforts by our members to
recognize a loved one and spread knowledge about Immuno-Oncology,
an area of cancer research that is providing a new sense of hope
for those affected by cancer.”
In 2015, the 23 participating advocacy organizations were:
- Addario Lung Cancer Foundation
- AIM at Melanoma
- American Brain Tumor Association
- CancerCare
- Cancer Research Institute
- Cancer Support Community
- Chris4Life Colon Cancer Foundation
- Colon Cancer Alliance
- Debbie’s Dream Foundation: Curing
Stomach Cancer
- Fight Colorectal Cancer
- Free to Breathe
- Head and Neck Cancer Alliance
- Kidney Cancer Association
- The Leukemia & Lymphoma
Society
- Lung Cancer Alliance
- Lung Cancer Foundation of America
- Melanoma International Foundation
- Melanoma Research Alliance
- Melanoma Research Foundation
- Multiple Myeloma Research
Foundation
- Skin Cancer Foundation
- Support for People with Oral and Head
and Neck Cancer
- Stand Up To Cancer
Please visit www.ReadyRaiseRise.com to raise your flag to
support a loved one and learn more about Immuno-Oncology
research.
Immuno-Oncology at Bristol-Myers Squibb
Surgery, radiation, cytotoxic or targeted therapies have
represented the mainstay of cancer treatment over the last several
decades, but long-term survival and a positive quality of life have
remained elusive for many patients with advanced disease.
To address this unmet medical need, Bristol-Myers Squibb is
leading research in an innovative field of cancer research and
treatment known as Immuno-Oncology, which involves agents whose
primary mechanism is to work directly with the body’s immune system
to fight cancer. The company is exploring a variety of compounds
and immunotherapeutic approaches for patients with different types
of cancer, including researching the potential of combining
Immuno-Oncology agents that target different pathways in the
treatment of cancer.
Bristol-Myers Squibb is committed to advancing the science of
Immuno-Oncology, with the goal of changing survival
expectations and the way patients live with cancer.
About Bristol-Myers Squibb
Bristol-Myers Squibb is a global biopharmaceutical company whose
mission is to discover, develop and deliver innovative medicines
that help patients prevail over serious diseases. For more
information about Bristol-Myers Squibb, visit www.bms.com, or
follow us on Twitter at http://twitter.com/bmsnews.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20151013005628/en/
Bristol-Myers SquibbMedia:Laurel Sacks,
609-897-2944Laurel.sacks@bms.comorKate Fisher,
917-301-8406Kate.fisher@ogilvy.com
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From Apr 2024 to May 2024
Bristol Myers Squibb (NYSE:BMY)
Historical Stock Chart
From May 2023 to May 2024